- Cyclerion Therapeutics Inc Clinical Data Update from Study of CY6463 in CIAS Webinar TranscriptJul 28, 2022
- Cyclerion Therapeutics Inc Call to Discuss CY6463 MELAS Clinical Data TranscriptJun 28, 2022
- Cyclerion Therapeutics Inc Pipeline Update Webinar Corporate Call TranscriptApr 27, 2021
- Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Cyclerion Therapeutics, Inc. - Special Call TranscriptOct 14, 2020
- Cyclerion Therapeutics, Inc. - Special Call TranscriptJul 09, 2020
- Cyclerion Therapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Cyclerion Therapeutics, Inc. - Special Call TranscriptOct 30, 2019
- Cyclerion Therapeutics Inc Investor Webcast Event TranscriptSep 17, 2019
- Cyclerion Therapeutics Inc Corporate Overview Call TranscriptMay 13, 2019
Cyclerion Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, ladies and gentlemen. This is Marsha Fanucci, Chair of the Board of Directors of Cyclerion Therapeutics. I'd like to welcome you all and call to order the 2020 Annual Meeting of Stockholders of Cyclerion Therapeutics. Due to the public health concerns related to the COVID-19 pandemic, we are hosting today's meeting through this virtual online platform. I will act as the chair of this meeting, and Anjeza Gjino will act as secretary of the meeting.
It's my pleasure to introduce the other members of the Board of Directors, certain officers and invited guests who are present for this Annual Meeting. All of our directors are present. In addition to me, they are Kevin Churchwell, George Conrades, Peter Hecht, Ole Isacson, Stephanie Lovell, Terrance McGuire, Michael Mendelsohn and Amy Schulman. Officers present, in addition to our CEO Peter Hecht, are Mark Currie, Andreas Busch and Bill Huyett. Also present are Andrea Wikerd of Ernst & Young LLP, our independent accountants; and Gary Simon of Hughes Hubbard &
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)